Evaluation of JNJ-26489112 in patients with photosensitive epilepsy: A placebo-controlled, exploratory study

Single oral doses of JNJ-26489112 were well-tolerated and the pharmacodynamic effects appeared to be dose-related in patients with idiopathic, photosensitive epilepsy.